Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
Instagram Outage Disrupts Thousands of U.S. Users 
SAN FRANCISCO, Nov. 03, 2016 -- Hagens Berman Sobol Shapiro LLP alerts investors in Adeptus Health Inc. (NYSE:ADPT) to the securities class action lawsuit filed in the U.S. District Court for the Eastern District of Texas and the Lead Plaintiff deadline of December 27, 2016.
If you acquired securities of Adeptus in its Secondary Public Offering on or about July 31, 2015 or between April 23, 2015 and November 16, 2015 and suffered over $50,000 in losses, contact Hagens Berman Sobol Shapiro LLP. For more information visit:
https://www.hbsslaw.com/cases/ADPT
or contact Reed Kathrein, who is leading the firm’s investigation, by calling 510-725-3000 or emailing [email protected].
On November 17, 2015, an NBC-affiliated television station in Denver, Colorado reported that certain Adeptus Colorado facilities engaged in a pattern and practice of overbilling patients. In response, the price of Adeptus shares fell over 22% to $46.50 on November 17, 2015.
Adeptus failed to disclose their alleged practice of overbilling, instead conducting two secondary public offerings in 2014 and 2015 that reaped over $500 million in net proceeds. Hagens Berman continues to investigate further potential wrongdoing.
“SEC rules are quite clear that issuers must disclose to investors known trends or uncertainties that reasonably could have a material negative impact on the issuer,” said Hagens Berman partner Reed Kathrein. “Adeptus’ predatory conduct, if true, should have been disclosed to investors.”
Whistleblowers: Persons with non-public information regarding Adeptus should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new SEC whistleblower program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 510-725-3000 or email [email protected].
About Hagens Berman
Hagens Berman is a national investor-rights law firm headquartered in Seattle, Washington with offices in 10 cities. The Firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the Firm and its successes can be found at www.hbsslaw.com. Read the Firm’s Securities Newsletter, and visit the blog. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.
Contact: Reed Kathrein, 510-725-3000
